Istanbul Retina Institute, Istanbul, Turkey.
Retina. 2018 Mar;38(3):569-577. doi: 10.1097/IAE.0000000000001562.
To evaluate the anatomical and functional outcomes after endoresection of complex retinal capillary hemangioblastoma (RCH).
Retrospective case series of 12 patients (13 eyes), all treated with pars plana vitrectomy, endodiathermy of feeding and draining vessels, endoresection of RCH and silicone oil injection.
The mean age at the time of surgery was 32.5 ± 15.9 years. The mean follow-up duration after initial surgery was 50.5 ± 49.4 months. Indications for surgery included RCH with associated complications such as tractional retinal detachment in five eyes (38%), exudative retinal detachment in four eyes (31%), and combination of tractional retinal detachment and exudative retinal detachment in four eyes (31%). The dimensions of the resected RCHs were as follows: >3.0 mm in seven eyes (54%), >3.5 mm in three eyes (23%), and >4.0 mm in three eyes (23%). No tumor was located closer than 10 mm to the optic nerve or fovea. Anatomical success after initial surgery was 92%. One eye had a second vitreoretinal procedure owing to recurrent RD. The mean preoperative Snellen visual acuity was 20/303. The mean Snellen visual acuity at the final visit was 20/73. At the final visit, visual acuity had improved in seven eyes (54%), and six eyes (46%) were stable. Short-term complications included recurrent proliferative vitreoretinopathy in one eye (8%), transient ocular hypertension requiring topical antiglaucoma treatment in four eyes (31%), and long-term complications included progression of cataract in seven eyes (54%).
Combined pars plana vitrectomy, endodiathermy of feeding and draining vessels, endoresection of RCH, and silicone oil injection may be an effective treatment option for complex RCH, achieving high anatomical success and stable or even improved visual acuity, acceptable rates of disease- and treatment-related complications, and minimal need for retreatment.
评估复杂视网膜毛细血管瘤(RCH)经内切除术后的解剖和功能结果。
回顾性系列病例研究,共纳入 12 名患者(13 只眼),均接受经平坦部玻璃体切除术、供养和引流血管内电凝、RCH 内切除和硅油注射治疗。
手术时的平均年龄为 32.5±15.9 岁。初次手术后的平均随访时间为 50.5±49.4 个月。手术指征包括伴有牵拉性视网膜脱离(5 只眼,38%)、渗出性视网膜脱离(4 只眼,31%)、牵拉性和渗出性视网膜脱离并存(4 只眼,31%)等并发症的 RCH。切除的 RCH 尺寸如下:>3.0mm(7 只眼,54%)、>3.5mm(3 只眼,23%)和>4.0mm(3 只眼,23%)。无肿瘤位于距视盘或黄斑 10mm 以内。初次手术后解剖学成功 92%。1 只眼因 RD 复发而再次行玻璃体视网膜手术。术前最佳矫正视力(Snellen 视力)平均为 20/303。末次随访时的平均 Snellen 视力为 20/73。末次随访时,7 只眼(54%)视力改善,6 只眼(46%)视力稳定。短期并发症包括 1 只眼(8%)复发性增生性玻璃体视网膜病变、4 只眼(31%)短暂性眼压升高需行局部抗青光眼治疗,长期并发症包括 7 只眼(54%)白内障进展。
经平坦部玻璃体切除术、供养和引流血管内电凝、RCH 内切除和硅油注射联合治疗复杂 RCH 可能是一种有效的治疗选择,可实现较高的解剖学成功率和稳定或甚至改善的视力,疾病和治疗相关并发症发生率可接受,且再次治疗的需求最小。